Table 5.
LT4 therapy | ECLIA-Cobas | CLIA-LIAISON | ||
---|---|---|---|---|
fT4 [pmol/L] | ||||
R s | p-Value | R s | p-Value | |
Salivary fT4 [pg/mL] | ||||
Yes N = 32 |
0.307 | 0.113 | 0.124 | 0.530 |
No N = 10 |
0.898 | 0.002 a | 0.849 | 0.004 a |
fT3 [pg/mL] | ||||
R s | p-Value | R s | p-Value | |
Salivary fT3 [pg/mL] | ||||
Yes N = 32 |
0.271 | 0.163 | 0.156 | 0.429 |
No N = 10 |
0.898 | 0.002 a | 0.728 a | 0.026 a |
p-value < 0.05.
TSH, thyroid stimulating hormone; fT4, thyroxine; fT3, tri-iodothyronine; LT4 levothyroxine; ECLIA-Cobas, electrochemiluminescence (ECLIA) immunoassays Elecsys® Cobas e801, Roche; CLIA-LIAISON, chemiluminescence immunoassay (CLIA) LIAISON XL®, DiaSorin; Rs, Spearman’s correlation coefficients.